Galván-Talamantes Y, Espinoza de los Monteros-Estrada I

Idioma: Español
Referencias bibliográficas: 10
Paginas: 345-348
Archivo PDF: 206.33 Kb.

FRAGMENTO

SEPSIS Y ANESTESIA

Sepsis y choque séptico representan una de las principales causas de ingreso a las unidades de cuidados intensivos; siendo este último principal causa de muerte en estas unidades.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-1554.

2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35:1414-1415.

3. Sessler CN, Perry JC, Varney KL. Management of severe sepsis and septic shock. Curr Opin Crit Care. 2004;10:354-363.

4. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31:946-955.

5. Hotchkiss RS. The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348(2):138-150.

6. Kumar. Myocardial dysfunction in septic shock. Crit Care Clin. 2000;16:251-287.

7. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;113:227-242.

8. Arnold RC, Shapiro NI, Jones AE, Schorr C, Pope J, Casner E et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32:35-39.

9. Dellinger RP, Carlet JM, Masur H. Surviving Sepsis Campaign guidelines for management of severe sepsis and shock. Crit Care Med. 2008;32:858-873.

10. Perner A, Haase N. Hydroxyethyl Starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012;367:124-134.